Tehran University of Medical Sciences

Science Communicator Platform

Share By
Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome Publisher Pubmed



Daneshjou D1 ; Soleimani Mehranjani M1 ; Zadeh Modarres S2 ; Shariatzadeh MA1
Authors

Source: Trends in Endocrinology and Metabolism Published:2020


Abstract

Metformin has long been used in the treatment of polycystic ovarian syndrome (PCOS). Recently, sitagliptin has been reported to improve ovarian cycles and ovulation in PCOS. We suggest that a combination of sitagliptin and metformin can be more effective than either treatment alone in improving different aspects of PCOS. © 2020 Elsevier Ltd